Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Class A Common Stock, par value $0.01
-
Shares outstanding
-
316M
-
Number of holders
-
157
-
Total 13F shares, excl. options
-
116M
-
Shares change
-
+7.67M
-
Total reported value, excl. options
-
$1.57B
-
Value change
-
+$89.7M
-
Put/Call ratio
-
0
-
Number of buys
-
63
-
Number of sells
-
-87
-
Price
-
$13.53
Significant Holders of Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) as of Q4 2018
184 filings reported holding AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 as of Q4 2018.
Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) has 157 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 116M shares
of 316M outstanding shares and own 36.77% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (19.6M shares), Fosun International Ltd (19.6M shares), WELLINGTON MANAGEMENT GROUP LLP (16M shares), Vanguard Group Inc (9.11M shares), FMR LLC (7.31M shares), BlackRock Inc. (6.05M shares), TPG Group Holdings (SBS) Advisors, Inc. (3.88M shares), FRONTIER CAPITAL MANAGEMENT CO LLC (2.45M shares), JANUS HENDERSON GROUP PLC (2.43M shares), and Viking Global Investors LP (2.35M shares).
This table shows the top 157 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.